Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.19p
   
  • Change Today:
      0.030p
  • 52 Week High: 3.42p
  • 52 Week Low: 0.85p
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 299,353
  • Market Cap: £9.12m
  • RiskGrade: 328

Regulatory News

Grant of Share Options 19-Apr-2024 07:00 RNS
New intellectual property strategy initiated 02-Apr-2024 07:03 RNS
Incanthera provides Comm'l Update/Revenue F'casts 25-Mar-2024 07:25 RNS
Grant of Share Options 19-Mar-2024 07:00 RNS
Financial, Business and Portfolio Develop't Update 06-Mar-2024 07:00 RNS
Holding(s) in Company 28-Dec-2023 13:35 RNS
Holding(s) in Company 19-Dec-2023 14:50 RNS
Simbec-Orion appointed as CRO 19-Dec-2023 07:00 RNS
Incanthera - Comm'l Skincare Deal/£1M... 18-Dec-2023 07:15 RNS
Holding(s) in Company 13-Sep-2023 15:47 RNS
Result of Retail Offer and Director Shareholding 07-Sep-2023 07:00 RNS
WRAP Retail Offer for up to £0.5m 31-Aug-2023 07:02 RNS
Subscription to raise £1.35m; Sharing Agr, ... 31-Aug-2023 07:01 RNS
Interim results 31-Aug-2023 07:00 RNS
Extension of warrants in Incanthera plc 21-Aug-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.19p
Change Today 0.030p
% Change 1.39 %
52 Week High 3.42p
52 Week Low 0.85p
Volume 299,353
Shares Issued 416.44m
Market Cap £9.12m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average
9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average
Price Trend
26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average
43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average43.86% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
09:24 50 @ 2.27p
08:20 20,000 @ 2.19p
08:20 44,052 @ 2.27p
08:19 18,107 @ 2.11p
08:00 204,754 @ 2.11p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page